One journey. One legacy. One mission. One movement

We are a team of many, with the focus of one – pushing the frontiers of cancer research, treatment and prevention.

Twenty years in the making

As we stand together reflecting on our rich history, we embrace the cause that unites us.


Alvin and Ruth Siteman’s gift of $35 million establishes the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.


The 14-story Center for Advanced Medicine opens. The building consolidates the cancer-related outpatient services of WUSM and Barnes-Jewish Hospital and houses the Alvin J. Siteman Cancer Center.


Siteman Cancer Center is awarded the prestigious Comprehensive Cancer Center designation from the NCI, placing Siteman among the most highly ranked cancer institutions in the nation. Learn more about our NCI designation.


Siteman Cancer Center is selected to join the National Comprehensive Cancer Network (NCCN), an alliance of the world’s premier cancer centers, charged with setting the standard for cancer care.


Timothy J. Ley, MD; Elaine Mardis, PhD; and Richard Wilson, PhD, working in conjunction with many colleagues at The Genome Center and Siteman Cancer Center, sequence the first human cancer genome from a patient with acute myeloid leukemia (AML), as published in Nature.


The Institute for Public Health at Washington University is established through a partnership of Siteman Cancer Center, Washington University School of Medicine and the George Warren Brown School of Social Work.


Siteman Cancer Center performs its 5,000th bone marrow transplant, placing it among the top five cancer centers in the United States.


The Kling Center for Proton Therapy, the first single-vault proton therapy center in the country, opens at Siteman Cancer Center’s main campus.


The world’s first MRI-guided radiation therapy treatment is performed at Siteman Cancer Center. The treatment technique allows tumors to be visualized and treatment adapted.


The NCI awards Siteman an “exceptional” rating, based on a rigorous review of Siteman’s research programs. The rating, which accompanies Siteman’s re-certification as a Comprehensive Cancer Center, is the highest possible by the NCI.


Siteman and St. Louis Children’s Hospital establish “Siteman Kids at St. Louis Children’s Hospital,” a partnership focused on caring for children and adolescents with cancer.


Siteman becomes one of the first cancer centers nationwide to offer the newly approved CAR-T cell therapy called Yescarta. CAR-T cell therapy involves extracting a patient’s own T cells and supercharging them to home in on cancer cells and destroy them.


The NCI awards Washington University researchers and physicians a second $11.3 million, five-year Specialized Program of Research Excellence (SPORE) grant to further high-level investigations into leukemia and related blood cancers.